Mechanism of Action: DNA Polymerase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: DNA Polymerase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Macleods Pharms Ltd | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 212444-001 | May 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Yiling | ACYCLOVIR | acyclovir | CAPSULE;ORAL | 212173-001 | Sep 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Zydus Pharms | ACYCLOVIR | acyclovir | TABLET;ORAL | 204314-001 | Aug 19, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Apotex Inc | ACYCLOVIR | acyclovir | TABLET;ORAL | 077309-001 | Sep 29, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Amneal Pharms | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 204605-001 | Jun 18, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan Pharms Inc | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 202459-001 | Apr 3, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |